SRp55 Regulates a Splicing Network That Controls Human Pancreatic β-Cell Function and Survival.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 29246973.
- Also identified by DOI 10.2337/db17-0736 and PMC identifier 5828453.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Progressive failure of insulin-producing β-cells is the central event leading to diabetes, but the signaling networks controlling β-cell fate remain poorly understood. Here we show that SRp55, a splicing factor regulated by the diabetes susceptibility gene <i>GLIS3</i>, has a major role in maintaining the function and survival of human β-cells. RNA sequencing analysis revealed that SRp55 regulates the splicing of genes involved in cell survival and death, insulin secretion, and c-Jun N-terminal kinase (JNK) signaling. In particular, SRp55-mediated splicing changes modulate the function of the proapoptotic proteins BIM and BAX, JNK signaling, and endoplasmic reticulum stress, explaining why SRp55 depletion triggers β-cell apoptosis. Furthermore, SRp55 depletion inhibits β-cell mitochondrial function, explaining the observed decrease in insulin release. These data unveil a novel layer of regulation of human β-cell function and survival, namely alternative splicing modulated by key splicing regulators such as SRp55, that may cross talk with candidate genes for diabetes.
Medical subject headings
- Alternative Splicing
- Apoptosis
- Bcl-2-Like Protein 11
- Insulin
- Insulin-Secreting Cells
- Phosphoproteins
- Serine-Arginine Splicing Factors
- bcl-2-Associated X Protein